Therapy Insight: diabetes and drug-eluting stents
Victor Legrand
Correspondence Service de Cardiologie, CHU de Liège Sart-Tilman, 4000 Liège, Belgium
Email vlegrand@chu.ulg.ac.be
Individuals with diabetes mellitus have worse outcomes, and particularly a higher rate of restenosis, following revascularization than those without diabetes. The advent of drug-eluting stents has, however, reignited enthusiasm for percutaneous coronary intervention in individuals with diabetes. In this Review, Victor Legrand evaluates drug-eluting stents as an alternative revascularization strategy to surgery in diabetic patients.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access graftsKidney International Original Article
See all 22 matches for Research